Cardiotoxicity refers to the harmful effects that can damage the heart muscle and surrounding tissues or interfere with its electrical function. The potential for drug-induced cardiotoxicity is a concern across various therapeutic classes, affecting medications ranging from antineoplastic agents to psychotropic drugs. Thus, early and reliable assessment of cardiotoxicity has become increasingly critical during drug development. This necessity has led to a focus on alternative models and methods for drug safety evaluation, with zebrafish gaining significant traction due to their unique advantages.
The zebrafish (Danio rerio) is a highly effective model organism for studying various biological processes, including cardiovascular development and genetic implications. Recent studies indicate that zebrafish offer substantial predictive value for assessing drug responses in humans. Research has shown that zebrafish exhibit alignment with human drug responses, achieving predictability rates of 78% and 70%. This impressive correlation is attributed to the similarities in cardiac structure, including the presence of specialized chambers, valves, and electrical systems that regulate heart rhythm.
Moreover, zebrafish embryos provide an excellent platform for extensive toxicology screenings. Advances in echocardiography techniques, including speckle-tracking analysis, enable non-invasive evaluation of cardiac performance, allowing researchers to monitor real-time changes in heart function and morphology with unprecedented precision.
Creative Biogene is dedicated to leveraging zebrafish models to facilitate robust assessments of drug-induced cardiotoxicity. Our services enhance the understanding of cardiotoxic effects and provide a streamlined in vivo model for screening drug candidates early in the development process.
Utilizing zebrafish for cardiotoxicity assays presents several advantages:
For more information on how we can assist in evaluating the cardiotoxicity potential of your candidates, feel free to reach out to us through our contact page.
About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2026 MolecularCloud